Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas

Journal of Oral Pathology and Medicine

Volumn 27, Issue 7, 1998, Pages 303-307

  Oliveira, D T ^a,b   Sherriff, M ^a   Odell, E W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alternative splicing; Antigens; Carcinoma; CD44; Head and neck neoplasms; Squamous cell

Indexed keywords

EID: 0032146946     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01961.x     Document Type: Article

References (24)

1. HERRLICH P, ZOLLER M, PALS ST, PONTA H. CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993; 14: 395-9.
2. GUNTHERT U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 184: 47-63.
3. SCREATON GR, BELL MY BELL JI, JACKSON DG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 1993; 268: 12235-8.
4. HOFMANN M, RUDY W, ZOLLER. M, et al. CD44 splice variants confer metastatic behavior in rats, homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-7.
5. TANABE KK, SAYA H. The CD44 adhesion molecule and metastasis. Crit Rev Oncog 1994; 5: 201-12.
6. ZOLLER M. CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Molec Med 1995; 73. 425-38.
7. YOSHIDA K, BOLODEOKU J, SUGINO T, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 1995; 55: 4273-7.
8. MATSUMURA Y, SUGIYAMA M, MATSUMURA S, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995; 177: 11-20.
9. KAUFMANN M, HEIDER KH, SINN HP, VON MINCKWITZ G, PONTA H, HERRLICH P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-9.
10. HUDSON DL, SLEEMAN J, WATT FM. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 1995; 108: 1959 70.
11. HEROLD-MENDE C, SEITER S, BORNO A, et al. Expression of CD44 splice variants in squamous epithelia and squamous carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
12. HUDSON DL, SPEIGHT PM, WATT FM. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Int J Cancer 1996; 66: 457-63.
13. OLIVEIRA DT, ODELL EW. Expression of CD44 variant exons by normal oral epithelia. Oral Oncol 1997; 33: 260-2.
14. SALMI M, GRON-VIRTA K, SOINTU P, GRENMAN R, KALIMO H, JALKANEN S. Regulated expression of exon v6 containing isoforms of CD44 in man: down-regulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993; 122: 431-42.
15. PIFFKO J, BANKFALVI A, KLAUTE K. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med 1996; 25: 502-6.
16. MACFARLANE GJ, BOYLE P, SCULLY C. Oral cancer in Scotland: changing incidence and mortality. BMJ 1992; 305: 1121-3.
17. MOLLER H. Changing incidence of cancer of the tongue, oral cavity and pharynx in Denmark. J Oral Pathol Med 1989; 18: 224-9.
18. HERMANEK P, SOBIN LH, eds. UICC TNM Classification of malignant tumours, 4th edn, 2nd rev. Berlin: Springer-Verlag, 1992.
19. Fox SB, FAWCETT J, JACKSON DG, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms Cancer Res 1994; 54: 4539-46.
20. CATTORETTI G, BECKER MH, KEY G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63.
21. BRYNE M, KOPPANG HS, LILLENG R, KJAERHEIM A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992; 166: 375-81.
22. ANNEROTH G, BATSAKIS J, LUNA M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987; 95: 229-49.
23. ODELL EW, JANI P, SHERRIFF M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 1994; 74: 789-94.
24. MEHTA CR, PATEL NR, SENDCHAUDHURI P. Importance sampling for estimating exact probabilities in permutational inference. J Am Stat Assoc 1988; 83: 999-1005.